Yash D. Shah, Ian Tobal, Sameera Shuaibi, Dhaval Patel, Allen Zhou, Meena Mishra, Susan Olet, Lingling Du. "Real-world evidence of response to
                    <sup>177</sup>
                    Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) based on primary and metastatic sites in patients (pts) with neuroendocrine tumor (NET).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16317